MedPath

Evaluation of the effect of oral Dydrogesterone (Duphaston) in threatened abortion at first trimester

Phase 2
Conditions
Threatened abortion.
Threatened abortion
Registration Number
IRCT20120918010876N5
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
170
Inclusion Criteria

Pregnant women in the first trimester
Presence of symptoms and signs of threatened abortion
Singleton pregnancy
Having an ultrasound report with viable fetus

Exclusion Criteria

The presence of underlying illnesses such as high blood pressure, diabetes
Known allergy to dystrogesterone components

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Abortion. Timepoint: Daily check from the beginning of the study up to 20 weeks. Method of measurement: Observation and clinical symptoms.;Vaginal bleeding. Timepoint: At the beginning of the study and after starting the study until the end of the study. Method of measurement: Amount and number of sanitary pads.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath